CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.96
-2.72 (-4.21%)
Nov 2, 2026, 4:00 PM EST - Market closed
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.49 billion as of November 2, 2026. It is the 3,355th most valuable company in the world and the 1,099th biggest in the United States. Its market cap has increased by 66.47% in one year.
Market Cap
5.49B
Enterprise Value
4.47B
1-Year Change
66.47%
Global Rank
Country Rank
#1,099 United States
Category
ChartMarket Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.49B, an increase of 355.34%. That is a compound annual growth rate of 72.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 5.49B | 63.98% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.43B |
| Oruka Therapeutics | 6.41B |
| Rhythm Pharmaceuticals | 6.37B |
| Belite Bio | 6.23B |
| Kodiak Sciences | 6.22B |
| Immunovant | 6.03B |
| Veradermics | 5.84B |
| Mirum Pharmaceuticals | 5.52B |